148 related articles for article (PubMed ID: 37580183)
1. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: The importance of treatment response rather than bacteremia duration.
Kim SH; Jeon M; Jang S; Mun SJ
J Microbiol Immunol Infect; 2023 Oct; 56(5):1007-1015. PubMed ID: 37580183
[TBL] [Abstract][Full Text] [Related]
2. Association of methicillin resistance with mortality of hospital-acquired
Aratani T; Tsukamoto H; Higashi T; Kodawara T; Yano R; Hida Y; Iwasaki H; Goto N
J Int Med Res; 2021 Nov; 49(11):3000605211058872. PubMed ID: 34826374
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Cohort Study of Durations of
Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
[TBL] [Abstract][Full Text] [Related]
4. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.
Park SY; Chong YP; Park HJ; Park KH; Moon SM; Jeong JY; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
Infection; 2013 Feb; 41(1):111-9. PubMed ID: 23065454
[TBL] [Abstract][Full Text] [Related]
5. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
6. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
[TBL] [Abstract][Full Text] [Related]
7. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
10. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
11. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Smith JR; Frens JJ; Snider CB; Claeys KC
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
[TBL] [Abstract][Full Text] [Related]
12. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
[TBL] [Abstract][Full Text] [Related]
13. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
14. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.
López-Cortés LE; Gálvez-Acebal J; Del Toro MD; Velasco C; de Cueto M; Caballero FJ; Muniain MA; Pascual A; Rodríguez-Baño J
PLoS One; 2013; 8(12):e82958. PubMed ID: 24376617
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
16. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
[TBL] [Abstract][Full Text] [Related]
17. Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes.
Minejima E; Mai N; Bui N; Mert M; Mack WJ; She RC; Nieberg P; Spellberg B; Wong-Beringer A
Clin Infect Dis; 2020 Feb; 70(4):566-573. PubMed ID: 30949675
[TBL] [Abstract][Full Text] [Related]
18. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
19. Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled Cohort Study.
Thorlacius-Ussing L; Sandholdt H; Nissen J; Rasmussen J; Skov R; Frimodt-Møller N; Dahl Knudsen J; Østergaard C; Benfield T
Clin Infect Dis; 2021 Sep; 73(5):866-872. PubMed ID: 33677515
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults.
Bassetti M; Righi E; Del Giacomo P; Sartor A; Ansaldi F; Trucchi C; Alicino C; Trecarichi EM; Spanu T; Paganino C; Tumbarello M; Carnelutti A
J Am Geriatr Soc; 2018 Jul; 66(7):1284-1289. PubMed ID: 29664994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
